Pepdox
Studies
Peptides
Calculator
Oral Semaglutide Sustains Long-Term CVD Risk Factor Reductions. | Pepdox
Home
/
Search
/
PMID 42030062
Oral Semaglutide Sustains Long-Term CVD Risk Factor Reductions.
JAMA
2026
PMID: 42030062
View on PubMed
DOI: 10.1001/jama.2026.2123
Semaglutide
Authors
Anderer, Samantha